Cell Genesys
1
28M
1
0.03
1
- Areas of investment
Summary
In 1988 was created Cell Genesys, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Hayward. The company was established in North America in United States.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2007. The top amount of exits for fund were in 2013. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Cell Genesys, startups are often financed by MPM Capital, HamiltonApex Technology Ventures, California Technology Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Investor Growth Capital Limited, Hamilton BioVentures. In the next rounds fund is usually obtained by Michael J. Fox Foundation.
This organization was formed by Larry Green, Raju Kucherlapati, Robert Tepper.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biotechnology. Among the various public portfolio startups of the fund, we may underline Ceregene
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.03
- Investments by industry
- Biotechnology (1)
- Health Diagnostics (1)
- Pharmaceutical (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ceregene | 22 Jun 2007 | Biotechnology, Health Diagnostics, Pharmaceutical | Late Stage Venture | 28M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.